Literature DB >> 2546151

The v-sea oncogene of avian erythroblastosis retrovirus S13: another member of the protein-tyrosine kinase gene family.

D R Smith1, P K Vogt, M J Hayman.   

Abstract

The cloning and sequencing of the oncogene of the avian erythroblastosis virus S13 is described. The oncogene, termed v-sea, was found to be another member of the protein-tyrosine kinase gene family. The oncogene was fused in frame with the retrovirus S13 envelope gene, thus generating a fusion protein with a structure resembling that of a growth factor receptor. Sequence comparisons revealed that the v-sea gene was most closely related to the insulin receptor family of protein-tyrosine kinases, the greatest similarity being with the human MET oncogene.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546151      PMCID: PMC297607          DOI: 10.1073/pnas.86.14.5291

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Temperature-sensitive v-sea transformed erythroblasts: a model system to study gene expression during erythroid differentiation.

Authors:  J Knight; M Zenke; C Disela; E Kowenz; P Vogt; J D Engel; M J Hayman; H Beug
Journal:  Genes Dev       Date:  1988-02       Impact factor: 11.361

2.  Isolation of a transplantable cell line induced by the MC29 avian leukosis virus.

Authors:  A J Langlois; K Lapis; R Ishizaki; J W Beard; D P Bolognesi
Journal:  Cancer Res       Date:  1974-06       Impact factor: 12.701

3.  The use of heparin as a simple cost-effective means of controlling background in nucleic acid hybridization procedures.

Authors:  L Singh; K W Jones
Journal:  Nucleic Acids Res       Date:  1984-07-25       Impact factor: 16.971

Review 4.  The sea oncogene of the avian erythroblastosis virus S13.

Authors:  M J Hayman
Journal:  Pathol Immunopathol Res       Date:  1987

5.  The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1.

Authors:  C J Sherr; C W Rettenmier; R Sacca; M F Roussel; A T Look; E R Stanley
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

6.  Lambdoid phages that simplify the recovery of in vitro recombinants.

Authors:  N E Murray; W J Brammar; K Murray
Journal:  Mol Gen Genet       Date:  1977-01-07

7.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.

Authors:  J Downward; Y Yarden; E Mayes; G Scrace; N Totty; P Stockwell; A Ullrich; J Schlessinger; M D Waterfield
Journal:  Nature       Date:  1984 Feb 9-15       Impact factor: 49.962

8.  A system for shotgun DNA sequencing.

Authors:  J Messing; R Crea; P H Seeburg
Journal:  Nucleic Acids Res       Date:  1981-01-24       Impact factor: 16.971

9.  Hematopoietic growth factor glycosylation. Multiple forms of chicken myelomonocytic growth factor.

Authors:  A Leutz; H Beug; C Walter; T Graf
Journal:  J Biol Chem       Date:  1988-03-15       Impact factor: 5.157

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  16 in total

1.  A myristylated form of the sea oncoprotein can transform chicken embryo fibroblasts.

Authors:  A J Crowe; M J Hayman
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

2.  Characterization of a member of the immunoglobulin gene superfamily that possibly represents an additional class of growth factor receptor.

Authors:  Y H Chou; M J Hayman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

3.  Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3.

Authors:  K Keegan; D E Johnson; L T Williams; M J Hayman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

4.  The protooncogene c-sea encodes a transmembrane protein-tyrosine kinase related to the Met/hepatocyte growth factor/scatter factor receptor.

Authors:  J L Huff; M A Jelinek; C A Borgman; T J Lansing; J T Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

Review 5.  MSP-RON signalling in cancer: pathogenesis and therapeutic potential.

Authors:  Hang-Ping Yao; Yong-Qing Zhou; Ruiwen Zhang; Ming-Hai Wang
Journal:  Nat Rev Cancer       Date:  2013-07       Impact factor: 60.716

Review 6.  Tyrosine kinase inhibitors in preclinical development.

Authors:  M L Levitt; P P Koty
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

7.  Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway.

Authors:  A Danilkovitch-Miagkova; A Miagkov; A Skeel; N Nakaigawa; B Zbar; E J Leonard
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

8.  A point mutation in the MET oncogene abrogates metastasis without affecting transformation.

Authors:  S Giordano; A Bardelli; Z Zhen; S Menard; C Ponzetto; P M Comoglio
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

9.  A novel oncogene, v-ryk, encoding a truncated receptor tyrosine kinase is transduced into the RPL30 virus without loss of viral sequences.

Authors:  R Jia; B J Mayer; T Hanafusa; H Hanafusa
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

10.  Role of oligomerization of the S13 Env-Sea oncoprotein in cell transformation.

Authors:  A M Morimoto; M J Hayman
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.